TruBridge, Inc. (TBRG) Aktienanalyse

Unternehmensübersicht

TruBridge, Inc. operates as a provider of comprehensive healthcare solutions and services designed for community hospitals, clinics, and various healthcare systems across the United States and international markets. The company functions within the Healthcare sector, specifically focusing on the Health Information Services industry, which implies a specialization in the management and processing of medical data and financial workflows for medical institutions. With a market capitalization of $262.96M and a workforce comprising 3,500 employees, TruBridge demonstrates a significant operational footprint within its niche. The annual revenue of $346.84M indicates that the company generates substantial cash flow through its two primary segments, Financial Health and Patient Care, establishing it as a notable entity in the revenue cycle management landscape. These valuation and revenue figures suggest that the company holds a established position capable of supporting a large employee base while serving a broad geographic range of healthcare clients.

Finanzielle Gesundheit

The company reported a trailing twelve-month revenue of $346.84M with a corresponding net income of $4.21M and an EBITDA of $38.41M. The substantial disparity between the revenue figure and the net income reveals a cost structure where operating expenses, such as salaries for the 3,500 employees and overhead costs, consume the majority of gross earnings before reaching the bottom line. Free cash flow stands at $29.63M, which signifies that the company generates sufficient operational cash to cover capital expenditures and potentially fund internal initiatives without relying solely on external financing. When analyzing profitability margins, the gross margin is recorded at 53.0%, indicating that the company retains more than half of its revenue after direct costs. However, the operating margin sits at 2.0% and the profit margin at 1.3%, highlighting a highly competitive environment where general and administrative expenses heavily impact the final profitability. On the balance sheet, total cash holdings of $24.85M are significantly outweighed by total debt of $166.74M, resulting in a debt-to-equity ratio of 93.70, which characterizes the company as a highly leveraged entity rather than one with a conservative debt profile. The current ratio of 1.80 suggests that the company possesses 1.80 units of current assets for every unit of current liabilities, indicating a comfortable but not excessive short-term liquidity position. Furthermore, the return on equity is 2.5% and the return on assets is 3.9%, metrics that reflect the efficiency of management in generating returns relative to the shareholders' equity and the total asset base, respectively.

Bewertungsanalyse

The trailing P/E ratio is 60.41, while the forward P/E is significantly lower at 5.98, a divergence that implies the market expects a dramatic shift in earnings trajectory or a re-rating of the stock based on anticipated future performance. The price-to-book ratio stands at 1.43, indicating that the market values the company at 43% above its book value, which may reflect intangible assets or growth expectations despite the current low profitability. Additional valuation metrics show a price-to-sales ratio of 0.76 and an EV/EBITDA of 10.29, suggesting that the stock is priced at a fraction of its sales revenue but carries a valuation multiple relative to earnings that is moderate for a leveraged firm. In terms of trading range, the 52-week high is $27.15 and the 52-week low is $13.88, meaning the current price sits at a point relative to this range that reflects recent market volatility without necessarily indicating a breakout or breakdown. The beta value is 0.76, which indicates that the stock's price volatility is less than that of the broader market, suggesting it may act as a defensive position within a diversified portfolio despite its high leverage.

Growth & Income

Revenue growth year-over-year is recorded at 0.0%, while earnings growth is marked as N/A, indicating a stagnation in top-line expansion during the most recent reporting period. The lack of revenue growth suggests that the company is currently operating in a mature market phase where organic expansion has halted, and any earnings changes are likely driven by margin adjustments rather than volume increases. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, as indicated by the 0.0% figure, meaning that retained earnings are theoretically available for reinvestment rather than shareholder distributions. Although the earnings growth is N/A due to the low absolute net income of $4.21M, the absence of a dividend policy implies that management prioritizes retaining capital over paying out cash, a strategy often seen in companies with high debt loads or those seeking to rebuild liquidity buffers. The overall growth and income profile presents a company with stagnant revenue, no current income distribution, and a reliance on operational efficiency to navigate its highly leveraged balance sheet.